SFG
GILD icon

Southern Financial Group’s Gilead Sciences GILD Stock Holding History

Southern Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
2,143
+11
+0.5% +$1.45K 0.07% 72
2026
Q1 		$297K Buy
2,132
+12
+0.6% +$1.68K 0.08% 63
2025
Q4 		$260K Buy
+2,120
New +$258K 0.07% 67

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Southern Financial Group's GILD Position: Q2 2026 in Review

Southern Financial Group increased its Gilead Sciences (GILD) stake by 0.52% in Q2 2026, buying an estimated $1.45K and bringing the position to 2,143 shares worth $271K. The position accounts for 0.07% of the portfolio, ranked #72.

Southern Financial Group first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $297K in Q1 2026. 1,244 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Southern Financial Group held 2,143 shares of Gilead Sciences worth $271K as of Q2 2026.
  • Southern Financial Group bought 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up 0.07% of Southern Financial Group's portfolio in Q2 2026, its #72 holding.
  • Southern Financial Group first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Southern Financial Group's Gilead Sciences position peaked at $297K in Q1 2026.
  • 1,244 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Southern Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.